IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 783 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission

 


This article has been cited by
1Potential repurposed SARS-CoV-2 (COVID-19) infection drugs
Gamal El-Din A. Abuo-Rahma,Mamdouh F. A. Mohamed,Tarek S. Ibrahim,Mai E. Shoman,Ebtihal Samir,Rehab M. Abd El-Baky
RSC Advances.2020;10(45)26895
[DOI]
2New perspective towards therapeutic regimen against SARS-CoV-2 infection
Vartika Srivastava,Aijaz Ahmad
Journal of Infection and Public Health.2021;14(7)852
[DOI]
3SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets
Jayalakshmi Vallamkondu,Albin John,Willayat Yousuf Wani,Suguru Pathinti Ramadevi,Kishore Kumar Jella,P. Hemachandra Reddy,Ramesh Kandimalla
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2020;1866(10)165889
[DOI]
4In silico identification of widely used and well-tolerated drugs as potential SARS-CoV-2 3C-like protease and viral RNA-dependent RNA polymerase inhibitors for direct use in clinical trials
Seref Gul,Onur Ozcan,Sinan Asar,Alper Okyar,Ibrahim Baris,Ibrahim Halil Kavakli
Journal of Biomolecular Structure and Dynamics.2020;1866(10)1
[DOI]
5The Potential Therapeutic Effect of RNA Interference and Natural Products on COVID-19: A Review of the Coronaviruses Infection
Mohammad Reza Kalhori,Fatemeh Saadatpour,Ehsan Arefian,Masoud Soleimani,Mohammad Hosien Farzaei,Ina Yosifova Aneva,Javier Echeverría
Frontiers in Pharmacology.2021;12(10)1
[DOI]
6Combating COVID-19: The role of drug repurposing and medicinal plants
Shah A. Khan,K. Al-Balushi
Journal of Infection and Public Health.2021;14(4)495
[DOI]
7Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update
Uttpal Anand,Shweta Jakhmola,Omkar Indari,Hem Chandra Jha,Zhe-Sheng Chen,Vijay Tripathi,José M. Pérez de la Lastra
Frontiers in Immunology.2021;12(4)495
[DOI]
8Uncaria tomentosa (cat’s claw): a promising herbal medicine against SARS-CoV-2/ACE-2 junction and SARS-CoV-2 spike protein based on molecular modeling
Andres F. Yepes-Pérez,Oscar Herrera-Calderon,Jorge Quintero-Saumeth
Journal of Biomolecular Structure and Dynamics.2020;12(4)1
[DOI]
9Virtual screening of phytoconstituents from miracle herb nigella sativa targeting nucleocapsid protein and papain-like protease of SARS-CoV-2 for COVID-19 treatment
Sahabjada Siddiqui,Shivbrat Upadhyay,Rumana Ahmad,Anamika Gupta,Aditi Srivastava,Anchal Trivedi,Ishrat Husain,Bilal Ahmad,Maqusood Ahamed,Mohsin Ali Khan
Journal of Biomolecular Structure and Dynamics.2020;12(4)1
[DOI]
10COVID-19 Infection: Concise Review Based on the Immunological Perspective
Parisa Lotfinejad,Zahra Asadzadeh,Shiva Najjary,Mohammad Hossein Somi,Khalil Hajiasgharzadeh,Ahad Mokhtarzadeh,Afshin Derakhshani,Elmira Roshani,Behzad Baradaran
Immunological Investigations.2020;12(4)1
[DOI]
11In silico screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2
Mithun Rudrapal,Abdul Rashid Issahaku,Clement Agoni,Atul R. Bendale,Akhil Nagar,Mahmoud E. S. Soliman,Deepak Lokwani
Journal of Biomolecular Structure and Dynamics.2021;12(4)1
[DOI]
12A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin
Anwarul Hasan,Bilal Ahamad Paray,Arif Hussain,Fikry Ali Qadir,Farnoosh Attar,Falah Mohammad Aziz,Majid Sharifi,Hossein Derakhshankhah,Behnam Rasti,Masoumeh Mehrabi,Koorosh Shahpasand,Ali Akbar Saboury,Mojtaba Falahati
Journal of Biomolecular Structure and Dynamics.2021;39(8)3025
[DOI]
13COVID-19: Learning from Lessons To Guide Treatment and Prevention Interventions
Chris R. Triggle,Devendra Bansal,Elmoubasher Abu Baker Abd Farag,Hong Ding,Ali A. Sultan,Helene F. Rosenberg
mSphere.2020;5(3)3025
[DOI]
14Chloroquine: A Potential Drug in the COVID-19 Scenario
Ranjana Singh,Viji Vijayan
Transactions of the Indian National Academy of Engineering.2020;5(2)399
[DOI]
15Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19
Elise Klement-Frutos,Sonia Burrel,Gilles Peytavin,Stéphane Marot,Minh P. Lê,Nagisa Godefroy,Vincent Calvez,Anne-Geneviève Marcelin,Eric Caumes,Valérie Pourcher,David Boutolleau
Journal of Infection.2021;82(1)159
[DOI]
16Transcriptome network analyses in human coronavirus infections suggest a rational use of immunomodulatory drugs for COVID-19 therapy
Henry Sung-Ching Wong,Chin-Lin Guo,Gan-Hong Lin,Kang-Yun Lee,Yukinori Okada,Wei-Chiao Chang
Genomics.2021;113(2)564
[DOI]
17Pandemic COVID-19 caused by SARS-CoV-2: genetic structure, vaccination, and therapeutic approaches
Hany E. Marei,Asmaa Althani,Nahla Afifi,Giacomo Pozzoli,Thomas Caceci,Franco Angelini,Carlo Cenciarelli
Molecular Biology Reports.2021;48(9)6513
[DOI]
18Exploitation of polyphenols and proteins using nanoencapsulation for anti-viral and brain boosting properties – Evoking a synergistic strategy to combat COVID-19 pandemic
Nairah Noor,Adil Gani,Asir Gani,Asima Shah,Zanoor ul Ashraf
International Journal of Biological Macromolecules.2021;180(9)375
[DOI]
19An Overview of COVID-19: Focus on Pharmacological Aspect
Nandhini Saravanabavan,Padmavathi Shanmuganathan,Manimekalai Kumarappan,Kartik J Salwe,Barathane Datchanamurthy,Johan Pandian,R Sudar Codi,Vimala Ananthy,Kamalasundar Thanuskodi,Uma Narayanamurthy
SBV Journal of Basic, Clinical and Applied Health Science.2020;3(2)75
[DOI]
20Targeting C-terminal Helical bundle of NCOVID19 Envelope (E) protein
Shruti Mukherjee,Amaravadhi Harikishore,Anirban Bhunia
International Journal of Biological Macromolecules.2021;175(2)131
[DOI]
21Comprehensive In Silico Screening of the Antiviral Potentialities of a New Humulene Glucoside from Asteriscus hierochunticus against SARS-CoV-2
Vincent O. Imieje,Ahmed A. Zaki,Ahmed M. Metwaly,Ahmad E. Mostafa,Eslam B. Elkaeed,Abiodun Falodun,Wagdy Eldehna
Journal of Chemistry.2021;2021(2)1
[DOI]
22A Summary of Viral Targets and Recently Released PDB IDs of SARS-CoV-2
Rohit Bhatia,Raj K. Narang,Ravindra K. Rawal
The Open Virology Journal.2020;14(1)7
[DOI]
23Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CLpro)
Shruti Koulgi,Vinod Jani,Mallikarjunachari Uppuladinne,Uddhavesh Sonavane,Asheet Kumar Nath,Hemant Darbari,Rajendra Joshi
Journal of Biomolecular Structure and Dynamics.2021;39(15)5735
[DOI]
24Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2
Manisha Prajapat,Nishant Shekhar,Phulen Sarma,Pramod Avti,Sanjay Singh,Hardeep Kaur,Anusuya Bhattacharyya,Subodh Kumar,Saurabh Sharma,Ajay Prakash,Bikash Medhi
Journal of Molecular Graphics and Modelling.2020;101(15)107716
[DOI]
25Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review
Francesco Di Gennaro,Damiano Pizzol,Claudia Marotta,Mario Antunes,Vincenzo Racalbuto,Nicola Veronese,Lee Smith
International Journal of Environmental Research and Public Health.2020;17(8)2690
[DOI]
26Computational basis of SARS-CoV 2 main protease inhibition: an insight from molecular dynamics simulation based findings
Pramod Avti,Arushi Chauhan,Nishant Shekhar,Manisha Prajapat,Phulen Sarma,Hardeep Kaur,Anusuya Bhattacharyya,Subodh Kumar,Ajay Prakash,Saurabh Sharma,Bikash Medhi
Journal of Biomolecular Structure and Dynamics.2021;17(8)1
[DOI]
27India Fights Back: COVID-19 Pandemic
Kamal Kant Sahu,Ajay Kumar Mishra,Amos Lal,Shamendra Anand Sahu
Heart & Lung.2020;49(5)446
[DOI]
28FAVIPIRAVIR AS A POTENTIAL DRUG IN THE TREATMENT OF COVID-19
Dany Geraldo Kramer,Maria Josilene Leonardo Da Silva,Gislanne Stéphanne Estevam Da Silva,Ana Maria Marinho Andrade De Moura,Geraldo Barroso Cavalcanti Junior,Anesio Mendes De Sousa,Ana Elizabeth Alves Da Silva
International Journal of Research -GRANTHAALAYAH.2020;8(4)7
[DOI]
29Cyanobacterial metabolites as promising drug leads against the Mpro and PLpro of SARS-CoV-2: an in silico analysis
Devashan Naidoo,Ayan Roy,Pallab Kar,Taurai Mutanda,Akash Anandraj
Journal of Biomolecular Structure and Dynamics.2021;39(16)6218
[DOI]
30A Potential Peptide From Soy Cheese Produced Using Lactobacillus delbrueckii WS4 for Effective Inhibition of SARS-CoV-2 Main Protease and S1 Glycoprotein
Rounak Chourasia,Srichandan Padhi,Loreni Chiring Phukon,Md Minhajul Abedin,Sudhir P. Singh,Amit Kumar Rai
Frontiers in Molecular Biosciences.2020;7(16)6218
[DOI]
31Ocular Surface and Conjunctival Cytology Findings in Patients With Confirmed COVID-19
Erdinç Bozkurt,Serdar Özates,Ersin Muhafiz,Fatma Yilmaz,Okan Caliskan
Eye & Contact Lens: Science & Clinical Practice.2021;47(4)168
[DOI]
32Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs
Shweta A. More,Akshay S. Patil,Nikhil S. Sakle,Santosh N. Mokale
Virology.2021;555(4)10
[DOI]
33Computational screening of FDA approved drugs of fungal origin that may interfere with SARS-CoV-2 spike protein activation, viral RNA replication, and post-translational modification: a multiple target approach
Rajveer Singh,Anupam Gautam,Shivani Chandel,Vipul Sharma,Arijit Ghosh,Dhritiman Dey,Syamal Roy,V. Ravichandiran,Dipanjan Ghosh
In Silico Pharmacology.2021;9(1)10
[DOI]
34Genomic Variation and Point mutations analysis of Indian COVID-19 patient samples submitted in GISAID database
Shikha Mudgal,Rohitash Yadav,Hoineiting Rebecca Haokip,Ananya Pandit,Y.Sheena Mary
Journal of the Indian Chemical Society.2021;9(1)100156
[DOI]
35In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain)
Phulen Sarma,Nishant Shekhar,Manisha Prajapat,Pramod Avti,Hardeep Kaur,Subodh Kumar,Sanjay Singh,Harish Kumar,Ajay Prakash,Deba Prasad Dhibar,Bikash Medhi
Journal of Biomolecular Structure and Dynamics.2021;39(8)2724
[DOI]
36The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19
Francis K. Yoshimoto
The Protein Journal.2020;39(3)198
[DOI]
37Investigational Drugs for the COVID 19 Pandemic – A Concise Review
Reena Sherin Parveen,Sherya Hegde,Veena Nayak
Pharmaceutical Sciences.2020;26(Covid-19)S36
[DOI]
38In Silico Structure-Based Repositioning of Approved Drugs for Spike Glycoprotein S2 Domain Fusion Peptide of SARS-CoV-2: Rationale from Molecular Dynamics and Binding Free Energy Calculations
Nishant Shekhar,Phulen Sarma,Manisha Prajapat,Pramod Avti,Hardeep Kaur,Anupam Raja,Harvinder Singh,Anusuya Bhattacharya,Saurabh Sharma,Subodh Kumar,Ajay Prakash,Bikash Medhi,Ileana M. Cristea
mSystems.2020;5(5)S36
[DOI]
39An update on antiviral antibody-based biopharmaceuticals
Shahrzad Ahangarzadeh,Zahra Payandeh,Roghaye Arezumand,Kiana Shahzamani,Fatemeh Yarian,Abbas Alibakhshi
International Immunopharmacology.2020;86(5)106760
[DOI]
40Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review
Susmit Mhatre,Tishya Srivastava,Shivraj Naik,Vandana Patravale
Phytomedicine.2021;85(5)153286
[DOI]
41What is Efficacy of Chloroquine/Hydroxychloroquine in Clinical Cure of SARS-CoV 2?; Evidence From an Iranian Population
Kiarash Ghazvini,Masoud Keikha
International Journal of Health and Life Sciences.2020;7(1)153286
[DOI]
42Genetic Risk Factors for the Development of COVID-19 Coronavirus Infection
O. S. Glotov,A. N. Chernov,S. G. Scherbak,V. S. Baranov
Russian Journal of Genetics.2021;57(8)878
[DOI]
43Vitamin C as prophylaxis and adjunctive medical treatment for COVID-19?
Adam F. Feyaerts,Walter Luyten
Nutrition.2020;79-80(8)110948
[DOI]
44Natural products and phytochemicals as potential anti-SARS-CoV -2 drugs
Myriam Merarchi,Namrata Dudha,Bhudev C Das,Manoj Garg
Phytotherapy Research.2021;79-80(8)110948
[DOI]
45Contributions of human ACE2 and TMPRSS2 in determining host–pathogen interaction of COVID-19
SABYASACHI SENAPATI,PRATIBHA BANERJEE,SANDILYA BHAGAVATULA,PREM PRAKASH KUSHWAHA,SHASHANK KUMAR
Journal of Genetics.2021;100(1)110948
[DOI]
46The importance of zinc in maintaining the activity of antiviral innate immunity proteins: analysis of publications on COVID-19
O.A. Gromova,I.Yu. Torshin
Profilakticheskaya meditsina.2020;23(3)131
[DOI]
47Emerging therapeutics for the management of COVID 19
Sujit Kumar Debnath,Rohit Srivastava,Abdelwahab Omri
Expert Opinion on Emerging Drugs.2020;25(3)337
[DOI]
48siRNA Therapeutics for the Therapy of COVID-19 and Other Coronaviruses
Muhammad Imran Sajid,Muhammad Moazzam,Yeseom Cho,Shun Kato,Ava Xu,J. J. Way,Sandeep Lohan,Rakesh K. Tiwari
Molecular Pharmaceutics.2021;18(6)2105
[DOI]
49Exploring Phytochemicals of Traditional Medicinal Plants Exhibiting Inhibitory Activity Against Main Protease, Spike Glycoprotein, RNA-dependent RNA Polymerase and Non-Structural Proteins of SARS-CoV-2 Through Virtual Screening
Saranya Nallusamy,Jayakanthan Mannu,Caroline Ravikumar,Kandavelmani Angamuthu,Bharathi Nathan,Kumaravadivel Nachimuthu,Gnanam Ramasamy,Raveendran Muthurajan,Mohankumar Subbarayalu,Kumar Neelakandan
Frontiers in Pharmacology.2021;12(6)2105
[DOI]
50Discovering small-molecule therapeutics against SARS-CoV-2
Vaibhav Tiwari,Jacob C. Beer,Nehru Viji Sankaranarayanan,Michelle Swanson-Mungerson,Umesh R. Desai
Drug Discovery Today.2020;25(8)1535
[DOI]
51Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a systematic review
Subodh Kumar,Phulen Sarma,Hardeep Kaur,Manisha Prajapat,Anusuya Bhattacharyya,Pramod Avti,Nishant Sehkhar,Harpinder Kaur,Seema Bansal,Saniya Mahendiratta,Vidya M. Mahalmani,Harvinder Singh,Ajay Prakash,Anurag Kuhad,Bikash Medhi
Tissue and Cell.2021;70(8)101497
[DOI]
52Mécanismes possiblement impliqués dans les effets antiviraux de la chloroquine et de l’hydroxychloroquine – Quelle réalité pour le traitement de la COVID-19 ?
Nessaibia Issam,Tichati Lazhari,Bouarroudj Tayeb,Siciliano Dafne,Bouslama Zihad,Merad Tarek,Tahraoui Abdelkrim
Toxicologie Analytique et Clinique.2021;70(8)101497
[DOI]
53Reverse vaccinology approach towards the in-silico multiepitope vaccine development against SARS-CoV-2
Vipul Kumar,Sudhakar Kancharla,Prachetha Kolli,Manoj Jena
F1000Research.2021;10(8)44
[DOI]
54Binding mechanism and structural insights into the identified protein target of COVID-19 and importin-a with in-vitro effective drug ivermectin
Parth Sarthi Sen Gupta,Satyaranjan Biswal,Saroj Kumar Panda,Abhik Kumar Ray,Malay Kumar Rana
Journal of Biomolecular Structure and Dynamics.2020;10(8)1
[DOI]
55Binding mechanism and structural insights into the identified protein target of COVID-19 and importin-a with in-vitro effective drug ivermectin
Shokouh Rezaei,Yahya Sefidbakht
Journal of Biomolecular Structure and Dynamics.2021;10(8)91
[DOI]
56Emerging Potential of Metallodrugs to Target Coronavirus: Efficacy, Toxicity and their Mechanism of Action
Yahya Pinki,Yahya Subhash,Ashu Chaudhary
Asian Journal of Chemistry.2021;33(6)1191
[DOI]
57Repurposing simeprevir, calpain inhibitor IV and a cathepsin F inhibitor against SARS-CoV-2 and insights into their interactions with Mpro
Abhithaj J,Dileep Francis,Sharanya C.S.,Arun K.G.,Sadasivan C.,E. Jayadevi Variyar
Journal of Biomolecular Structure and Dynamics.2020;33(6)1
[DOI]
58Targeting SARS-CoV-2 Receptor Binding Domain with Stapled Peptides: An In Silico Study
Luana Janaína de Campos,Nicholas Y. Palermo,Martin Conda-Sheridan
The Journal of Physical Chemistry B.2021;125(24)6572
[DOI]
59Possible prophylactic or preventive role of topical povidone iodine during accidental ocular exposure to 2019-nCoV
Phulen Sarma,Hardeep Kaur,Bikash Medhi,Anusuya Bhattacharyya
Graefe's Archive for Clinical and Experimental Ophthalmology.2020;258(11)2563
[DOI]
60Possible prophylactic or preventive role of topical povidone iodine during accidental ocular exposure to 2019-nCoV
Manpreet Singh,Kamal Kishore,Seshadri Reddy Ankireddy
Graefe's Archive for Clinical and Experimental Ophthalmology.2021;258(11)225
[DOI]
61In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro of SARS-CoV-2
Baby Krishnaprasad,Swastika Maity,Chetan Mehta,Akhil Suresh,Usha Y Nayak,Yogendra Nayak
Pharmaceutical Sciences.2020;26(Covid-19)S52
[DOI]
62Molecular diagnosis of COVID-19 in different biologic matrix, their diagnostic validity and clinical relevance: A systematic review
Saniya Mahendiratta,Gitika Batra,Phulen Sarma,Harish Kumar,Seema Bansal,Subodh Kumar,Ajay Prakash,Rakesh Sehgal,Bikash Medhi
Life Sciences.2020;258(Covid-19)118207
[DOI]
63Metallo therapeutics for COVID-19. Exploiting metal-based compounds for the discovery of new antiviral drugs
Damiano Cirri,Alessandro Pratesi,Tiziano Marzo,Luigi Messori
Expert Opinion on Drug Discovery.2021;16(1)39
[DOI]
64Knowing and combating the enemy: a brief review on SARS-CoV-2 and computational approaches applied to the discovery of drug candidates
Mateus S.M. Serafim,Jadson C. Gertrudes,Débora M.A. Costa,Patricia R. Oliveira,Vinicius G. Maltarollo,Kathia M. Honorio
Bioscience Reports.2021;41(3)39
[DOI]
65Corona virus versus existence of human on the earth: A computational and biophysical approach
Zainy Zehra,Manav Luthra,Sobia Manaal Siddiqui,Anas Shamsi,Naseem A. Gaur,Asimul Islam
International Journal of Biological Macromolecules.2020;161(3)271
[DOI]
66In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (Mpro)
Mohamed S. Alesawy,Abdallah E. Abdallah,Mohammed S. Taghour,Eslam B. Elkaeed,Ibrahim H. Eissa,Ahmed M. Metwaly
Molecules.2021;26(9)2806
[DOI]
67In silico screening and molecular dynamics of phytochemicals from Indian cuisine against SARS-CoV-2 MPro
Mala Rajendran,Sudeep Roy,Keerthana Ravichandran,Bagdevi Mishra,Deepak K. Gupta,Subash Nagarajan,Ruby Celsia Arul Selvaraj,Ivo Provaznik
Journal of Biomolecular Structure and Dynamics.2020;26(9)1
[DOI]
68Host-membrane interacting interface of the SARS coronavirus envelope protein: Immense functional potential of C-terminal domain
Shruti Mukherjee,Dipita Bhattacharyya,Anirban Bhunia
Biophysical Chemistry.2020;266(9)106452
[DOI]
69Improving the Cellular Selectivity of a Membrane-Disrupting Antimicrobial Agent by Monomer Control and by Taming
Steven L. Regen
Molecules.2021;26(2)374
[DOI]
70Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities
Siyu Xiu,Alexej Dick,Han Ju,Sako Mirzaie,Fatemeh Abdi,Simon Cocklin,Peng Zhan,Xinyong Liu
Journal of Medicinal Chemistry.2020;63(21)12256
[DOI]
71Coronavirus Disease-2019 (COVID-19): An Updated Review
Mithun Rudrapal,Shubham J. Khairnar,Laxmikant B. Borse,Anil G. Jadhav
Drug Research.2020;70(09)389
[DOI]
72Enfuvirtide, an HIV-1 fusion inhibitor peptide, can act as a potent SARS-CoV-2 fusion inhibitor: an in silico drug repurposing study
Khadijeh Ahmadi,Alireza Farasat,Mosayeb Rostamian,Behrooz Johari,Hamid Madanchi
Journal of Biomolecular Structure and Dynamics.2021;70(09)1
[DOI]
73In silico virtual screening, characterization, docking and molecular dynamics studies of crucial SARS-CoV-2 proteins
Meshari Alazmi,Olaa Motwalli
Journal of Biomolecular Structure and Dynamics.2020;70(09)1
[DOI]
74Antiviral activity of chlorpromazine, fluphenazine, perphenazine, prochlorperazine, and thioridazine towards RNA-viruses. A review
Michal Otreba,Leon Kosmider,Anna Rzepecka-Stojko
European Journal of Pharmacology.2020;887(09)173553
[DOI]
75Role of heterocyclic compounds in SARS and SARS CoV-2 pandemic
Meenakshi Negi,Pooja A. Chawla,Abdul Faruk,Viney Chawla
Bioorganic Chemistry.2020;104(09)104315
[DOI]
76Advances in gene-based vaccine platforms to address the COVID-19 pandemic
Deborah Pushparajah,Salma Jimenez,Shirley Wong,Hibah Alattas,Nafiseh Nafissi,Roderick A. Slavcev
Advanced Drug Delivery Reviews.2021;170(09)113
[DOI]
77Therapeutic development by repurposing drugs targeting SARS-CoV-2 spike protein interactions by simulation studies
Qazi Mohammad Sajid Jamal,Varish Ahmad,Ali H Alharbi,Mohammad Azam Ansari,Mohammad A Alzohairy,Ahmad Almatroudi,Saad Alghamdi,Mohammad N. Alomary,Sami AlYahya,Nashwa Talaat Shesha,Suriya Rehman
Saudi Journal of Biological Sciences.2021;28(8)4560
[DOI]
78Computer-aided drug design against spike glycoprotein of SARS-CoV-2 to aid COVID-19 treatment
Muhammad Shehroz,Tahreem Zaheer,Tanveer Hussain
Heliyon.2020;6(10)e05278
[DOI]
79Expanding Our Understanding of COVID-19 from Biomedical Literature Using Word Embedding
Heyoung Yang,Eunsoo Sohn
International Journal of Environmental Research and Public Health.2021;18(6)3005
[DOI]
80Critical neurological features of COVID-19: Role of imaging methods and biosensors for effective diagnosis
Vishakha Singh,Prince Allawadhi,Amit Khurana,Anil Kumar Banothu,Kala Kumar Bharani
Sensors International.2021;2(6)100098
[DOI]
81Molecular Docking and Molecular Dynamics Aided Virtual Search of OliveNet™ Directory for Secoiridoids to Combat SARS-CoV-2 Infection and Associated Hyperinflammatory Responses
Neelaveni Thangavel,Mohammad Al Bratty,Hassan Ahmad Al Hazmi,Asim Najmi,Reem Othman Ali Alaqi
Frontiers in Molecular Biosciences.2021;7(6)100098
[DOI]
82Comprehensive Consensus Analysis of SARS-CoV-2 Drug Repurposing Campaigns
Hazem Mslati,Francesco Gentile,Carl Perez,Artem Cherkasov
Journal of Chemical Information and Modeling.2021;61(8)3771
[DOI]
83Mass Spectrometry and Structural Biology Techniques in the Studies on the Coronavirus-Receptor Interaction
Danuta Witkowska
Molecules.2020;25(18)4133
[DOI]
84Structural and conformational analysis of SARS CoV 2 N-CTD revealing monomeric and dimeric active sites during the RNA-binding and stabilization: Insights towards potential inhibitors for N-CTD
Arushi Chauhan,Pramod Avti,Nishant Shekhar,Manisha Prajapat,Phulen Sarma,Anusuya Bhattacharyya,Subodh Kumar,Hardeep Kaur,Ajay Prakash,Bikash Medhi
Computers in Biology and Medicine.2021;134(18)104495
[DOI]
85Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic
Amin Gasmi,Sadaf Noor,Torsak Tippairote,Maryam Dadar,Alain Menzel,Geir Bjørklund
Clinical Immunology.2020;215(18)108409
[DOI]
86Mechanistic insight into anti-COVID-19 drugs: recent trends and advancements
Hardeep Singh Tuli,Shivani Sood,Jagjit Kaur,Pawan Kumar,Prachi Seth,Sandeep Punia,Priya Yadav,Anil Kumar Sharma,Diwakar Aggarwal,Katrin Sak
3 Biotech.2021;11(2)108409
[DOI]
87Designing Self-Inhibitory fusion peptide analogous to viral spike protein against novel severe acute respiratory syndrome (SARS-CoV-2)
Indra Singh,Shalini Singh,Krishna Kumar Ojha,Neetu Singh Yadav
Journal of Biomolecular Structure and Dynamics.2021;11(2)1
[DOI]
88Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs
Osama A. Badary
The Pharmacogenomics Journal.2021;21(3)275
[DOI]
89Emerging strategies on in silico drug development against COVID-19: challenges and opportunities
Manisha Yadav,Swasti Dhagat,J. Satya Eswari
European Journal of Pharmaceutical Sciences.2020;155(3)105522
[DOI]
90A Comprehensive Summary of the Knowledge on COVID-19 Treatment
Yu Peng,Hongxun Tao,Senthil Kumaran Satyanarayanan,Kunlin Jin,Huanxing Su
Aging and disease.2021;12(1)155
[DOI]
91Native Structure-Based Peptides as Potential Protein–Protein Interaction Inhibitors of SARS-CoV-2 Spike Protein and Human ACE2 Receptor
Norbert Odolczyk,Ewa Marzec,Maria Winiewska-Szajewska,Jaroslaw Poznanski,Piotr Zielenkiewicz
Molecules.2021;26(8)2157
[DOI]
92Coronavirus Disease 2019 and Herbal Therapy: Pertinent Issues Relating to Toxicity and Standardization of Phytopharmaceuticals
Kayode Komolafe,Titilope Ruth Komolafe,Toluwase Hezekiah Fatoki,Afolabi Clement Akinmoladun,Bartholomew I. C. Brai,Mary Tolulope Olaleye,Afolabi Akintunde Akindahunsi
Revista Brasileira de Farmacognosia.2021;31(2)142
[DOI]
93COVID-19 pandemic: potential phase III vaccines in development
Priya Saini
The Applied Biology & Chemistry Journal.2020;31(2)21
[DOI]
94COVID-19 pandemic: potential phase III vaccines in development
Manish Kumar Tripathi,Sujata Sharma,Tej P. Singh,A. S. Ethayathulla,Punit Kaur
The Applied Biology & Chemistry Journal.2021;923(2)273
[DOI]
95Virtual screening of phytochemical compounds as potential inhibitors against SARS-CoV-2 infection
Ram Kothandan,Cashlin Anna Suveetha Gnana Rajan,Janamitra Arjun,Rejoe Raymond Michael Raj,Sowfia Syed
Beni-Suef University Journal of Basic and Applied Sciences.2021;10(1)273
[DOI]
96Favipiravir for treating patients with novel coronavirus (COVID-19): protocol for a systematic review and meta-analysis of randomised clinical trials
Morteza Arab-Zozani,Soheil Hassanipour,Djavad Ghoddoosi-Nejad
BMJ Open.2020;10(7)e039730
[DOI]
97Clinical Characteristics, Diagnosis, and Treatment of Major Coronavirus Outbreaks
Rupinder Mann,Abhilash Perisetti,Mahesh Gajendran,Zainab Gandhi,Chandraprakash Umapathy,Hemant Goyal
Frontiers in Medicine.2020;7(7)e039730
[DOI]
98Binding insight of clinically oriented drug famotidine with the identified potential target of SARS-CoV-2
Parth Sarthi Sen Gupta,Satyaranjan Biswal,Dipankar Singha,Malay Kumar Rana
Journal of Biomolecular Structure and Dynamics.2021;39(14)5327
[DOI]
99An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants
Trina Ekawati Tallei,Trina Ekawati Fatimawali,Afriza Yelnetty,Rinaldi Idroes,Diah Kusumawaty,Talha Bin Emran,Talha Zahid Yesiloglu,Wolfgang Sippl,Shafi Mahmud,Taha Alqahtani,Ali M. Alqahtani,Saeed Asiri,Mohammed Rahmatullah,Rownak Jahan,Md. Arif Khan,Ismail Celik
Frontiers in Pharmacology.2021;12(14)5327
[DOI]
100CRISPR systems: Novel approaches for detection and combating COVID-19
Fatemeh Safari,Mohammad Afarid,Banafsheh Rastegari,Afshin Borhani-Haghighi,Mazyar Barekati-Mowahed,Abbas Behzad-Behbahani
Virus Research.2021;294(14)198282
[DOI]
101Computational and network pharmacology analysis of bioflavonoids as possible natural antiviral compounds in COVID-19
Rajesh Patil,Rupesh Chikhale,Pukar Khanal,Nilambari Gurav,Muniappan Ayyanar,Saurabh Sinha,Satyendra Prasad,Yadu Nandan Dey,Manish Wanjari,Shailendra S. Gurav
Informatics in Medicine Unlocked.2021;22(14)100504
[DOI]
102Strategies and Challenges to Develop Therapeutic Candidates against COVID-19 Pandemic
Rohit Bhatia,Subrahmanya S Ganti,Raj Kumar Narang,Ravindra Kumar Rawal
The Open Virology Journal.2020;14(1)16
[DOI]
103Comparative host–pathogen protein–protein interaction analysis of recent coronavirus outbreaks and important host targets identification
Abdul Arif Khan,Zakir Khan
Briefings in Bioinformatics.2021;22(2)1206
[DOI]
104Comparative host–pathogen protein–protein interaction analysis of recent coronavirus outbreaks and important host targets identification
Vinay Kumar,Kunal Roy
Briefings in Bioinformatics.2021;22(2)1206
[DOI]
105Remdesivir (GS-5734) as a therapeutic option of 2019-nCOV main protease – in silico approach
Vankudavath Raju Naik,Manne Munikumar,Ungarala Ramakrishna,Medithi Srujana,Giridhar Goudar,Pittla Naresh,Boiroju Naveen Kumar,Rajkumar Hemalatha
Journal of Biomolecular Structure and Dynamics.2021;39(13)4701
[DOI]
106Plants Metabolites: Possibility of Natural Therapeutics Against the COVID-19 Pandemic
Farhana Rumzum Bhuiyan,Sabbir Howlader,Topu Raihan,Mahmudul Hasan
Frontiers in Medicine.2020;7(13)4701
[DOI]
107Dual inhibition of SARS-CoV-2 spike and main protease through a repurposed drug, rutin
Anchala Kumari,Vikrant Singh Rajput,Priya Nagpal,Himanshi Kukrety,Sonam Grover,Abhinav Grover
Journal of Biomolecular Structure and Dynamics.2020;7(13)1
[DOI]
108In Silico Discovery of Antimicrobial Peptides as an Alternative to Control SARS-CoV-2
Yamil Liscano,Jose Oñate-Garzón,Iván Darío Ocampo-Ibáñez
Molecules.2020;25(23)5535
[DOI]
109Drug repurposing screens identify chemical entities for the development of COVID-19 interventions
Malina A. Bakowski,Nathan Beutler,Karen C. Wolff,Melanie G. Kirkpatrick,Emily Chen,Tu-Trinh H. Nguyen,Laura Riva,Namir Shaabani,Mara Parren,James Ricketts,Anil K. Gupta,Kastin Pan,Peiting Kuo,MacKenzie Fuller,Elijah Garcia,John R. Teijaro,Linlin Yang,Debashis Sahoo,Victor Chi,Edward Huang,Natalia Vargas,Amanda J. Roberts,Soumita Das,Pradipta Ghosh,Ashley K. Woods,Sean B. Joseph,Mitchell V. Hull,Peter G. Schultz,Dennis R. Burton,Arnab K. Chatterjee,Case W. McNamara,Thomas F. Rogers
Nature Communications.2021;12(1)5535
[DOI]
110Various theranostics and immunization strategies based on nanotechnology against Covid-19 pandemic: An interdisciplinary view
Sujan Chatterjee,Snehasis Mishra,Kaustav Dutta Chowdhury,Chandan Kumar Ghosh,Krishna Das Saha
Life Sciences.2021;278(1)119580
[DOI]
111Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19)
Amr El-Demerdash,Ahmed M. Metwaly,Afnan Hassan,Tarek Mohamed Abd El-Aziz,Eslam B. Elkaeed,Ibrahim H. Eissa,Reem K. Arafa,James D. Stockand
Biomolecules.2021;11(3)460
[DOI]
112Quantum dots as a promising agent to combat COVID-19
Selvambigai Manivannan,Kumar Ponnuchamy
Applied Organometallic Chemistry.2020;34(10)460
[DOI]
113

Cancer Care Management During the COVID-19 Pandemic

Ameneh Jafari,Mostafa Rezaei-Tavirani,Samira Karami,Mohsen Yazdani,Hakimeh Zali,Zahra Jafari
Risk Management and Healthcare Policy.2020;Volume 13(10)1711
[DOI]
114Current understanding on molecular drug targets and emerging treatment strategy for novel coronavirus-19
Khadga Raj,Karamjeet Kaur,G. D. Gupta,Shamsher Singh
Naunyn-Schmiedeberg's Archives of Pharmacology.2021;394(7)1383
[DOI]
115Fluoxetine Can Inhibit SARS-CoV-2 In Vitro
Arthur Dechaumes,Magloire Pandoua Nekoua,Sandrine Belouzard,Famara Sane,Ilka Engelmann,Jean Dubuisson,Enagnon Kazali Alidjinou,Didier Hober
Microorganisms.2021;9(2)339
[DOI]
116Repurposing of RdRp Inhibitors against SARS-CoV-2 through Molecular Docking Tools
Rohit Bhatia,Raj Kumar Narang,Ravindra Kumar Rawal
Coronaviruses.2020;1(1)108
[DOI]
117Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target
K. G. Arun,C. S Sharanya,J. Abhithaj,Dileep Francis,C. Sadasivan
Journal of Biomolecular Structure and Dynamics.2021;39(13)4647
[DOI]
118An immunoinformatics study on the spike protein of SARS-CoV-2 revealing potential epitopes as vaccine candidates
Arafat Islam Ashik,Mahedi Hasan,Atiya Tahira Tasnim,Md. Belal Chowdhury,Tanvir Hossain,Shamim Ahmed
Heliyon.2020;6(9)e04865
[DOI]
119An immunoinformatics study on the spike protein of SARS-CoV-2 revealing potential epitopes as vaccine candidates
Abhishek Chauhan
Heliyon.2021;6(9)169
[DOI]
120Model-informed drug repurposing: Viral kinetic modelling to prioritize rational drug combinations for COVID-19
Michael G. Dodds,Rajesh Krishna,Antonio Goncalves,Craig R. Rayner
British Journal of Clinical Pharmacology.2021;87(9)3439
[DOI]
121SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies
Ahmed M. Almehdi,Ghalia Khoder,Aminah S. Alchakee,Azizeh T. Alsayyid,Nadin H. Sarg,Sameh S. M. Soliman
Infection.2021;87(9)3439
[DOI]
122Screening of drug databank against WT and mutant main protease of SARS-CoV-2: Towards finding potential compound for repurposing against COVID-19
Tanuj Sharma,Mohammed Abohashrh,Mohammad Hassan Baig,Jae-June Dong,Mohammad Mahtab Alam,Irfan Ahmad,Safia Irfan
Saudi Journal of Biological Sciences.2021;28(5)3152
[DOI]
123A Review on the Effectivity of the Current COVID-19 Drugs and Vaccines: Are They Really Working Against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants?
Rashed Noor
Current Clinical Microbiology Reports.2021;8(3)186
[DOI]
124SARS-CoV-2 Infection and COVID-19 During Pregnancy: A Multidisciplinary Review
Kavita Narang,Elizabeth Ann L. Enninga,Madugodaralalage D.S.K. Gunaratne,Eniola R. Ibirogba,Ayssa Teles A. Trad,Amro Elrefaei,Regan N. Theiler,Rodrigo Ruano,Linda M. Szymanski,Rana Chakraborty,Vesna D. Garovic
Mayo Clinic Proceedings.2020;95(8)1750
[DOI]
125Virtual Screening for the Identification of Potential Candidate Molecules Against Envelope (E) and Membrane (M) Proteins of SARS-CoV-2
Abbas Alibakhshi,Mohammad Mehdi Ranjbar,Shaghayegh Haghjooy Javanmard,Fatemeh Yarian,Shahrzad Ahangarzadeh
Journal of Computational Biophysics and Chemistry.2021;20(03)209
[DOI]
1264-acetamido-3-nitrobenzoic acid - structural, quantum chemical studies, ADMET and molecular docking studies of SARS-CoV2
Shahrzad Gurumallappa,R. R. Arun Renganathan,M. K. Hema,C. S. Karthik,Sandhya Rani,M. Nethaji,H.S Jayanth,P. Mallu,N. K. Lokanath,V. Ravishankar Rai
Journal of Biomolecular Structure and Dynamics.2021;20(03)1
[DOI]
127Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2
Shravan B. Rathod,Pravin B. Prajapati,Lata B. Punjabi,Kuntal N. Prajapati,Neha Chauhan,Mohmedyasin F. Mansuri
In Silico Pharmacology.2020;8(1)1
[DOI]
128High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment
Biswajit Naik,Nidhi Gupta,Rupal Ojha,Satyendra Singh,Vijay Kumar Prajapati,Dhaneswar Prusty
International Journal of Biological Macromolecules.2020;160(1)1
[DOI]
129Computational Simulations Identified Marine-Derived Natural Bioactive Compounds as Replication Inhibitors of SARS-CoV-2
Vikas Kumar,Shraddha Parate,Sanghwa Yoon,Gihwan Lee,Keun Woo Lee
Frontiers in Microbiology.2021;12(1)1
[DOI]
130Computational drug re-purposing targeting the spike glycoprotein of SARS-CoV-2 as an effective strategy to neutralize COVID-19
Himanshu G. Toor,Devjani I. Banerjee,Soumya Lipsa Rath,Siddhi A. Darji
European Journal of Pharmacology.2021;890(1)173720
[DOI]
131Repurposing potential of posaconazole and grazoprevir as inhibitors of SARS-CoV-2 helicase
Syed Hani Abidi,Nahlah Makki Almansour,Daulet Amerzhanov,Khaled S. Allemailem,Wardah Rafaqat,Mahmoud A. A. Ibrahim,Philip la Fleur,Martin Lukac,Syed Ali
Scientific Reports.2021;11(1)173720
[DOI]
132Rapid and Sensitive Inhibitor Screening Using Magnetically Modulated Biosensors
Shira Roth,Amos Danielli
Sensors.2021;21(14)4814
[DOI]
133Receptor-Based Pharmacophore Modeling in the Search for Natural Products for COVID-19 Mpro
Mohd Saeed,Amir Saeed,Md Jahoor Alam,Mousa Alreshidi
Molecules.2021;26(6)1549
[DOI]
134The virus that shook the world: questions and answers about SARS-CoV-2 and COVID-19
Radostina Alexandrova,Pencho Beykov,Dobrin Vassilev,Marko Jukic,Crtomir Podlipnik
Biotechnology & Biotechnological Equipment.2021;35(1)74
[DOI]
135Druggability of cavity pockets within SARS-CoV-2 spike glycoprotein and pharmacophore-based drug discovery
Alireza Mohebbi,Fatemeh Sana Askari,Ali Salehnia Sammak,Mohsen Ebrahimi,Zahra Najafimemar
Future Virology.2021;16(6)389
[DOI]
136The potential role of Fluoroquinolones in the management of Covid-19 a rapid review
Zoheir A. Damanhouri,Huda M. Alkreathy,Ahmed S. Ali,Shahid Karim
Journal Of Advanced Pharmacy Education And Research.2021;11(1)128
[DOI]
137Single-Cell RNA-seq Identifies Cell Subsets in Human Placenta That Highly Expresses Factors Driving Pathogenesis of SARS-CoV-2
Nancy Ashary,Anshul Bhide,Priyanka Chakraborty,Stacy Colaco,Anuradha Mishra,Karisma Chhabria,Mohit Kumar Jolly,Deepak Modi
Frontiers in Cell and Developmental Biology.2020;8(1)128
[DOI]
138Pharmacological Properties of Zinc Drugs
G. V. Zaychenko,N. A. Gorchakova,O. V. Shumeiko,O. V. Klymenko,G. I. Doroshenko
Ukraïns'kij žurnal medicini, bìologìï ta sportu.2021;6(3)37
[DOI]
139Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discovery
P. Chellapandi,S. Saranya
Medicinal Chemistry Research.2020;29(10)1777
[DOI]
140Structure-Based Virtual Screening and Molecular Dynamics Simulation to Identify Potential SARS-CoV-2 Spike Receptor Inhibitors from Natural Compound Database
Arkadeep Sarkar,Debanjan Sen,Ashutosh Sharma,Ravi Kumar Muttineni,Sudhan Debnath
Pharmaceutical Chemistry Journal.2021;55(5)441
[DOI]
141Pharmacovigilance-based drug repurposing: The search for inverse signals via OpenVigil identifies putative drugs against viral respiratory infections
Ruwen Böhm,Claudia Bulin,Vicki Waetzig,Ingolf Cascorbi,Hans-Joachim Klein,Thomas Herdegen
British Journal of Clinical Pharmacology.2021;55(5)441
[DOI]
142A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19)
Amir Mirzaie,Mehrdad Halaji,Farhad Safarpoor Dehkordi,Reza Ranjbar,Hassan Noorbazargan
Complementary Therapies in Clinical Practice.2020;40(5)101214
[DOI]
143Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: A systematic review and meta-analysis
Phulen Sarma,Hardeep Kaur,Harish Kumar,Dhruv Mahendru,Pramod Avti,Anusuya Bhattacharyya,Manisha Prajapat,Nishant Shekhar,Subodh Kumar,Rahul Singh,Ashutosh Singh,Deba Prasad Dhibar,Ajay Prakash,Bikash Medhi
Journal of Medical Virology.2020;92(7)776
[DOI]
144Letter to the editor: Possible role of topical povidone iodine in case of accidental ocular exposure to SARS-CoV-2
Phulen Sarma,Hardeep Kaur,Bikash Medhi,Anusuya Bhattacharyya
Graefe's Archive for Clinical and Experimental Ophthalmology.2020;258(11)2575
[DOI]
145SARS-CoV-2: Insights into its structural intricacies and functional aspects for drug and vaccine development
Mandeep Kaur,Akanksha Sharma,Santosh Kumar,Gurpal Singh,Ravi P. Barnwal
International Journal of Biological Macromolecules.2021;179(11)45
[DOI]
146Using COVID -19 as a teaching tool in a time of remote learning: A workflow for bioinformatic approaches to identifying candidates for therapeutic and vaccine development
Samantha Bryce,Kevin N. Heath,Luca Issi,Elizabeth F. Ryder,Reeta Rao
Biochemistry and Molecular Biology Education.2020;48(5)492
[DOI]
147The identification of novel inhibitors of human angiotensin-converting enzyme 2 and main protease of Sars-Cov-2: A combination of in silico methods for treatment of COVID-19
Vahid Zarezade,Hamzeh Rezaei,Ghodratollah Shakerinezhad,Arman Safavi,Zahra Nazeri,Ali Veisi,Omid Azadbakht,Mahdi Hatami,Mohamad Sabaghan,Zeinab Shajirat
Journal of Molecular Structure.2021;1237(5)130409
[DOI]
148COVID-19 pandemic: protective role of vitamin D
O. A. Gromova,I. Yu. Torshin,G. Kh. Gabdulina
FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology.2020;13(2)132
[DOI]
149Computational prediction of potential siRNA and human miRNA sequences to silence orf1ab associated genes for future therapeutics against SARS-CoV-2
Mahedi Hasan,Arafat Islam Ashik,Md Belal Chowdhury,Atiya Tahira Tasnim,Zakia Sultana Nishat,Tanvir Hossain,Shamim Ahmed
Informatics in Medicine Unlocked.2021;24(2)100569
[DOI]
150Screening of Chloroquine, Hydroxychloroquine and its derivatives for their binding affinity to multiple SARS-CoV-2 protein drug targets
Mallikarjuna Nimgampalle,Vasudharani Devanathan,Ambrish Saxena
Journal of Biomolecular Structure and Dynamics.2021;39(14)4949
[DOI]
151Insilicoscreening of therapeutic potentials fromStrychnos nux-vomicaagainst the dimeric main protease (Mpro) structure of SARS-CoV-2
Birendra Kumar,P. Parasuraman,Thirupathihalli Pandurangappa Krishna Murthy,Manikanta Murahari,Vivek Chandramohan
Journal of Biomolecular Structure and Dynamics.2021;39(14)1
[DOI]
152In silico prediction of natural compounds as potential multi-target inhibitors of structural proteins of SARS-CoV-2
Jyoti Rani,Anasuya Bhargav,Faez Iqbal Khan,Srinivasan Ramachandran,Dakun Lai,Urmi Bajpai
Journal of Biomolecular Structure and Dynamics.2021;39(14)1
[DOI]
153Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review
Subham Das,Anu K.R.,Sumit Raosaheb Birangal,Ajinkya Nitin Nikam,Abhijeet Pandey,Srinivas Mutalik,Alex Joseph
Life Sciences.2020;258(14)118202
[DOI]
154The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis
Nicholas A. Wong,Milton H. Saier
International Journal of Molecular Sciences.2021;22(3)1308
[DOI]
155Evolutionary Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reveals Genomic Divergence with Implications for Universal Vaccine Efficacy
Nanda Kumar Yellapu,Shachi Patel,Bo Zhang,Richard Meier,Lisa Neums,Dong Pei,Qing Xia,Duncan Rotich,Rosalyn C. Zimmermann,Emily Nissen,Shelby Bell-Glenn,Whitney Shae,Jinxiang Hu,Prabhakar Chalise,Lynn Chollet-Hinton,Devin C. Koestler,Jeffery A. Thompson
Vaccines.2020;8(4)591
[DOI]
156A review on the effect of COVID-19 in type 2 asthma and its management
Srijit Ghosh,Srijita Das,Rupsa Mondal,Salik Abdullah,Shirin Sultana,Sukhbir Singh,Aayush Sehgal,Tapan Behl
International Immunopharmacology.2021;91(4)107309
[DOI]
157Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor
Ahmed A. Al-Karmalawy,Mohammed A. Dahab,Ahmed M. Metwaly,Sameh S. Elhady,Eslam B. Elkaeed,Ibrahim H. Eissa,Khaled M. Darwish
Frontiers in Chemistry.2021;9(4)107309
[DOI]
158Prospects for controlling future pandemics of SARS in highlights of SARS-CoV-2
Buddha Bahadur Basnet,Rajesh Basnet,Raju Panday
VirusDisease.2021;9(4)107309
[DOI]
159Membrane-Disrupting Molecules as Therapeutic Agents: A Cautionary Note
Steven L. Regen
JACS Au.2021;1(1)3
[DOI]
160CNS implications of COVID-19: a comprehensive review
Priyanka Nagu,Arun Parashar,Tapan Behl,Vineet Mehta
Reviews in the Neurosciences.2021;32(2)219
[DOI]
161Class A G Protein-Coupled Receptor Antagonist Famotidine as a Therapeutic Alternative against SARS-CoV2: An In Silico Analysis
Joseph T. Ortega,Maria Luisa Serrano,Beata Jastrzebska
Biomolecules.2020;10(6)954
[DOI]
162A review of novel coronavirus disease (COVID-19): based on genomic structure, phylogeny, current shreds of evidence, candidate vaccines, and drug repurposing
S. Udhaya Kumar,N. Madhana Priya,S. R. Nithya,Priyanka Kannan,Nikita Jain,D. Thirumal Kumar,R. Magesh,Salma Younes,Hatem Zayed,C. George Priya Doss
3 Biotech.2021;11(4)954
[DOI]
163Structure-activity relationship (SAR) and molecular dynamics study of withaferin-A fragment derivatives as potential therapeutic lead against main protease (Mpro) of SARS-CoV-2
Arabinda Ghosh,Monoswi Chakraborty,Anshuman Chandra,Mohamad Parvez Alam
Journal of Molecular Modeling.2021;27(3)954
[DOI]
164nCoV-2019 infection induced neurological outcome and manifestation, linking its historical ancestor SARS-CoV and MERS-CoV: a systematic review and meta-analysis
Ajay Prakash,Harvinder Singh,Phulen Sarma,Anusuya Bhattacharyya,Deba Prasad Dhibar,Neeraj Balaini,Ritu Shree,Manoj Goyal,Manish Modi,Bikash Medhi
Scientific Reports.2021;11(1)954
[DOI]
165Computational assessment of select antiviral phytochemicals as potential SARS-Cov-2 main protease inhibitors: molecular dynamics guided ensemble docking and extended molecular dynamics
Sanjay Sawant,Rajesh Patil,Manoj Khawate,Vishal Zambre,Vaibhav Shilimkar,Suresh Jagtap
In Silico Pharmacology.2021;9(1)954
[DOI]
166Identification of bioactive compounds from Glycyrrhiza glabra as possible inhibitor of SARS-CoV-2 spike glycoprotein and non-structural protein-15: a pharmacoinformatics study
Saurabh K. Sinha,Satyendra K. Prasad,Md Ataul Islam,Shailendra S. Gurav,Rajesh B. Patil,Nora Abdullah AlFaris,Tahany Saleh Aldayel,Nora M. AlKehayez,Saikh Mohammad Wabaidur,Anshul Shakya
Journal of Biomolecular Structure and Dynamics.2021;39(13)4686
[DOI]
167The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2)
Narasimha M. Beeraka,SubbaRao V. Tulimilli,Medha Karnik,Surya P. Sadhu,Rajeswara Rao Pragada,Gjumrakch Aliev,SubbaRao V. Madhunapantula,Jun Lu
BioMed Research International.2021;2021(13)1
[DOI]
168Study of Morphological Nature of Coronavirus: Causes and Prevention
Jun Meetkamal,R.K. Dwivedi
Journal of Pure and Applied Microbiology.2020;14(suppl 1)963
[DOI]
169Coronavirus disease 2019: scientific overview of the global pandemic
A. Dey,R. Das,H.S. Misra,S. Uppal
New Microbes and New Infections.2020;38(suppl 1)100800
[DOI]
170Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection
Biswa Mohan Sahoo,B. V. V. Ravi Kumar,J. Sruti,Manoj Kumar Mahapatra,Bimal K. Banik,Preetismita Borah
Frontiers in Molecular Biosciences.2021;8(suppl 1)100800
[DOI]
171Exploring the magic bullets to identify Achilles’ heel in SARS-CoV-2: Delving deeper into the sea of possible therapeutic options in Covid-19 disease: An update
Shikha Thakur,Shikha Mayank,Bibekananda Sarkar,Arshad J. Ansari,Akanksha Khandelwal,Anil Arya,Ramarao Poduri,Gaurav Joshi
Food and Chemical Toxicology.2021;147(suppl 1)111887
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow